Form 4: Sotera Health CEO Michael B. Petras Jr. Reports Stock Transactions
SEC Form 4 Filing
Sotera Health's CEO, Michael B. Petras Jr., reported the withholding of shares for tax obligations and the transfer of shares to a family trust.
Summary
- Michael B. Petras Jr., CEO of Sotera Health, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On November 20, 2024, 29,250 shares were withheld to cover tax obligations related to the vesting of restricted stock units (RSUs).
- On November 22, 2024, 39,243 shares were transferred to a grantor trust and another 39,243 shares were transferred to a family trust.
- The CEO still directly owns 670,499 shares and indirectly owns 5,214,337 shares through a grantor trust and 39,243 shares through a family trust.
- The report also lists various stock options held by the CEO with different exercise prices and vesting schedules.
Sentiment
Score: 6
Explanation: The document is neutral, reporting standard transactions. There is no indication of positive or negative sentiment, it is simply a report of stock transactions.
Positives
- The vesting of RSUs indicates the CEO is meeting performance or time-based requirements.
- The CEO continues to hold a significant number of shares and options, aligning his interests with shareholders.
Negatives
- The withholding of shares for tax obligations reduces the CEO's direct shareholding.
Risks
- The CEO's stock transactions could be perceived as a signal of his confidence in the company's future performance.
- Changes in ownership, even for tax or trust purposes, can sometimes create uncertainty in the market.
Industry Context
Form 4 filings are a standard part of regulatory compliance for publicly traded companies, providing transparency into the transactions of company insiders.
Comparison to Industry Standards
- Form 4 filings are a common practice across all publicly traded companies in the US, and the transactions reported by Mr. Petras are typical for executives receiving stock-based compensation.
- The vesting schedules and option grants are consistent with standard executive compensation packages in the industry.
- The use of trusts for estate planning and asset management is also a common practice among high-net-worth individuals, including corporate executives.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect standard executive compensation practices.
- The vesting of RSUs and the transfer of shares to trusts do not directly affect the company's operations or financial position.
Key Dates
| Date | Description |
|---|---|
| 11/20/2020 | Date of the original RSU grant that vested on 11/20/2024 |
| 03/02/2022 | Date of grant for stock options with a $20.03 exercise price. |
| 11/07/2022 | Date of grant for stock options with a $6.37 exercise price. |
| 03/06/2023 | Date of grant for stock options with a $17.59 exercise price. |
| 03/04/2024 | Date of grant for stock options with a $14.59 exercise price. |
| 11/20/2024 | Date of tax withholding of shares. |
| 11/22/2024 | Date of share transfers to grantor and family trusts. |
Keywords
Sotera Health, SHC, Michael B. Petras Jr., Form 4, Stock Options, Restricted Stock Units, Beneficial Ownership, Insider Trading, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.